Search research articles
Contact Us
Filters
Showing results (251-260 of 321) with videos related to
Page
of 33
Sort By:
Neurochemical Research
|
October 8, 2010
Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain
Rafal M Kaminski, Juan F Núñez-Taltavull, Bogusława Budziszewska, et al.
Drug and Alcohol Dependence
|
March 1, 1991
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine
J M Witkin, R E Johnson, J H Jaffe, et al.
European Journal of Pharmacology
|
August 4, 1995
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands
J B Acri, S R Carter, K Alling, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 22, 2001
Lobeline inhibits the neurochemical and behavioral effects of amphetamine
D K Miller, P A Crooks, L Teng, et al.
Frontiers in Psychiatry
|
June 20, 2012
Forced Abstinence from Cocaine Self-Administration is Associated with DNA Methylation Changes in Myelin Genes in the Corpus Callosum: a Preliminary Study
David A Nielsen, Wen Huang, Sara C Hamon, et al.
British Journal of Pharmacology
|
February 25, 2003
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
Eleni T Tzavara, Richard J Davis, Kenneth W Perry, et al.
Pharmacology & Therapeutics
|
November 6, 2013
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence
Jeffrey M Witkin, Michael A Statnick, Linda M Rorick-Kehn, et al.
Frontiers in Psychiatry
|
June 8, 2017
Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder
Michelle M Rodriguez, Carl Overshiner, J David Leander, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2022
Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies
Lalit K Golani, Md Yeunus Mian, Taukir Ahmed, et al.
Pharmacology & Therapeutics
|
November 18, 2021
GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA<sub>A</sub> receptors
Rok Cerne, Arnold Lippa, Michael M Poe, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 321) with videos related to
Sort By:
Page
of 33
Neurochemical Research
|
October 8, 2010
Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain
Rafal M Kaminski, Juan F Núñez-Taltavull, Bogusława Budziszewska, et al.
Drug and Alcohol Dependence
|
March 1, 1991
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine
J M Witkin, R E Johnson, J H Jaffe, et al.
European Journal of Pharmacology
|
August 4, 1995
Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands
J B Acri, S R Carter, K Alling, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 22, 2001
Lobeline inhibits the neurochemical and behavioral effects of amphetamine
D K Miller, P A Crooks, L Teng, et al.
Frontiers in Psychiatry
|
June 20, 2012
Forced Abstinence from Cocaine Self-Administration is Associated with DNA Methylation Changes in Myelin Genes in the Corpus Callosum: a Preliminary Study
David A Nielsen, Wen Huang, Sara C Hamon, et al.
British Journal of Pharmacology
|
February 25, 2003
The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions
Eleni T Tzavara, Richard J Davis, Kenneth W Perry, et al.
Pharmacology & Therapeutics
|
November 6, 2013
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence
Jeffrey M Witkin, Michael A Statnick, Linda M Rorick-Kehn, et al.
Frontiers in Psychiatry
|
June 8, 2017
Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder
Michelle M Rodriguez, Carl Overshiner, J David Leander, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 26, 2022
Rationalizing the binding and α subtype selectivity of synthesized imidazodiazepines and benzodiazepines at GABAA receptors by using molecular docking studies
Lalit K Golani, Md Yeunus Mian, Taukir Ahmed, et al.
Pharmacology & Therapeutics
|
November 18, 2021
GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA<sub>A</sub> receptors
Rok Cerne, Arnold Lippa, Michael M Poe, et al.
Page
of 33